238 related articles for article (PubMed ID: 10859337)
1. Fibroblasts as host cells in latent leishmaniosis.
Bogdan C; Donhauser N; Döring R; Röllinghoff M; Diefenbach A; Rittig MG
J Exp Med; 2000 Jun; 191(12):2121-30. PubMed ID: 10859337
[TBL] [Abstract][Full Text] [Related]
2. Dendritic cell populations in Leishmania major-infected skin and draining lymph nodes.
Baldwin T; Henri S; Curtis J; O'Keeffe M; Vremec D; Shortman K; Handman E
Infect Immun; 2004 Apr; 72(4):1991-2001. PubMed ID: 15039319
[TBL] [Abstract][Full Text] [Related]
3. Intradermal inoculations of low doses of Leishmania major and Leishmania amazonensis metacyclic promastigotes induce different immunoparasitic processes and status of protection in BALB/c mice.
Courret N; Lang T; Milon G; Antoine JC
Int J Parasitol; 2003 Oct; 33(12):1373-83. PubMed ID: 14527520
[TBL] [Abstract][Full Text] [Related]
4. Reactivation of latent leishmaniasis by inhibition of inducible nitric oxide synthase.
Stenger S; Donhauser N; Thüring H; Röllinghoff M; Bogdan C
J Exp Med; 1996 Apr; 183(4):1501-14. PubMed ID: 8666908
[TBL] [Abstract][Full Text] [Related]
5. Amastigote load and cell surface phenotype of infected cells from lesions and lymph nodes of susceptible and resistant mice infected with Leishmania major.
Muraille E; De Trez C; Pajak B; Torrentera FA; De Baetselier P; Leo O; Carlier Y
Infect Immun; 2003 May; 71(5):2704-15. PubMed ID: 12704145
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological evaluation of anti-leishmanial activity by in vivo nitric oxide modulation in Balb/c mice infected with Leishmania major MRHO/IR/75/ER: an Iranian strain of cutaneous leishmaniasis.
Nahrevanian H; Farahmand M; Aghighi Z; Assmar M; Amirkhani A
Exp Parasitol; 2007 Jul; 116(3):233-40. PubMed ID: 17335813
[TBL] [Abstract][Full Text] [Related]
7. Leishmania pifanoi pathogenesis: selective lack of a local cutaneous response in the absence of circulating antibody.
Colmenares M; Constant SL; Kima PE; McMahon-Pratt D
Infect Immun; 2002 Dec; 70(12):6597-605. PubMed ID: 12438331
[TBL] [Abstract][Full Text] [Related]
8. Dendritic cells in Leishmania major-immune mice harbor persistent parasites and mediate an antigen-specific T cell immune response.
Moll H; Flohé S; Röllinghoff M
Eur J Immunol; 1995 Mar; 25(3):693-9. PubMed ID: 7705398
[TBL] [Abstract][Full Text] [Related]
9. S-nitrosoglutathione (GSNO) is cytotoxic to intracellular amastigotes and promotes healing of topically treated Leishmania major or Leishmania braziliensis skin lesions.
Costa IS; de Souza GF; de Oliveira MG; Abrahamsohn Ide A
J Antimicrob Chemother; 2013 Nov; 68(11):2561-8. PubMed ID: 23788476
[TBL] [Abstract][Full Text] [Related]
10. Leishmania major reaches distant cutaneous sites where it persists transiently while persisting durably in the primary dermal site and its draining lymph node: a study with laboratory mice.
Nicolas L; Sidjanski S; Colle JH; Milon G
Infect Immun; 2000 Dec; 68(12):6561-6. PubMed ID: 11083765
[TBL] [Abstract][Full Text] [Related]
11. iNOS-producing inflammatory dendritic cells constitute the major infected cell type during the chronic Leishmania major infection phase of C57BL/6 resistant mice.
De Trez C; Magez S; Akira S; Ryffel B; Carlier Y; Muraille E
PLoS Pathog; 2009 Jun; 5(6):e1000494. PubMed ID: 19557162
[TBL] [Abstract][Full Text] [Related]
12. Parasitic load and histopathology of cutaneous lesions, lymph node, spleen, and liver from BALB/c and C57BL/6 mice infected with Leishmania mexicana.
Aguilar Torrentera F; Lambot MA; Laman JD; Van Meurs M; Kiss R; Noël JC; Carlier Y
Am J Trop Med Hyg; 2002 Mar; 66(3):273-9. PubMed ID: 12139220
[TBL] [Abstract][Full Text] [Related]
13. The protective Th1 response in mice is induced in the T-cell zone only three weeks after infection with Leishmania major and not during early T-cell activation.
Barthelmann J; Nietsch J; Blessenohl M; Laskay T; van Zandbergen G; Westermann J; Kalies K
Med Microbiol Immunol; 2012 Feb; 201(1):25-35. PubMed ID: 21547563
[TBL] [Abstract][Full Text] [Related]
14. NKT cells mediate organ-specific resistance against Leishmania major infection.
Mattner J; Donhauser N; Werner-Felmayer G; Bogdan C
Microbes Infect; 2006 Feb; 8(2):354-62. PubMed ID: 16239118
[TBL] [Abstract][Full Text] [Related]
15. Leishmania-derived murine monocyte chemoattractant protein 1 enhances the recruitment of a restrictive population of CC chemokine receptor 2-positive macrophages.
Conrad SM; Strauss-Ayali D; Field AE; Mack M; Mosser DM
Infect Immun; 2007 Feb; 75(2):653-65. PubMed ID: 17088347
[TBL] [Abstract][Full Text] [Related]
16. Effective clearance of intracellular Leishmania major in vivo requires Pten in macrophages.
Kuroda S; Nishio M; Sasaki T; Horie Y; Kawahara K; Sasaki M; Natsui M; Matozaki T; Tezuka H; Ohteki T; Förster I; Mak TW; Nakano T; Suzuki A
Eur J Immunol; 2008 May; 38(5):1331-40. PubMed ID: 18398930
[TBL] [Abstract][Full Text] [Related]
17. Ineffective elimination of Leishmania major by inflammatory (MRP14-positive) subtype of monocytic cells.
Steinbrink K; Schönlau F; Rescher U; Henseleit U; Vogel T; Sorg C; Sunderkötter C
Immunobiology; 2000 Nov; 202(5):442-59. PubMed ID: 11205374
[TBL] [Abstract][Full Text] [Related]
18. Leishmania tropica: suggestive evidences for the effect of infectious dose on pathogenicity and immunogenicity in an experimental model.
Rostamian M; Jafari D; Abolghazi M; Farahani H; Niknam HM
Parasitol Res; 2018 Sep; 117(9):2949-2956. PubMed ID: 29978420
[TBL] [Abstract][Full Text] [Related]
19. The role of polymorphonuclear leukocytes in the resistance to cutaneous Leishmaniasis.
Lima GM; Vallochi AL; Silva UR; Bevilacqua EM; Kiffer MM; Abrahamsohn IA
Immunol Lett; 1998 Dec; 64(2-3):145-51. PubMed ID: 9870666
[TBL] [Abstract][Full Text] [Related]
20. Endothelial nitric oxide synthase limits the inflammatory response in mouse cutaneous leishmaniasis.
Fritzsche C; Schleicher U; Bogdan C
Immunobiology; 2010; 215(9-10):826-32. PubMed ID: 20576313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]